FIELD: medicine.
SUBSTANCE: agent is presented in the form of a tablet, contains isoniazid and a substance which reduces its toxicity; as the substance which reduces the isoniazid toxicity, it contains thiotriazolin. The isoniazid/thiotriazolin ratio makes 4:1.
EFFECT: combined antituberculous drug ensures reducing toxicity as compared to the known ones and increasing its pharmacological activity.
2 cl, 1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTITUBERCULOUS COMPOSITE MEDICATION | 2009 |
|
RU2406518C1 |
PHARMACEUTICAL COMPOSITION WITH ANTI-TUBERCULOSIS EFFECT | 2006 |
|
RU2332216C2 |
ANTITUBERCULOUS TABLET | 2007 |
|
RU2363475C2 |
ANTITUBERCULOUS DRUG AND METHOD OF TREATING | 2010 |
|
RU2449797C1 |
COMBINED DRUG FOR PRIMARY NEUROPROTECTION | 2017 |
|
RU2636616C1 |
DIMEPHOSPHONE NICOTINOYLHYDRAZONE POSSESSING ANTI-TUBERCULOSIS ACTIVITY | 2011 |
|
RU2471787C1 |
DIMEPHOSPHONE ISONICOTINOYLHYDRAZONE WITH ANTI-TUBERCULOSIS ACTIVITY | 2011 |
|
RU2457212C1 |
SYNERGIC ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSERINE AND ZINC CONTAINING CONNECTION | 2016 |
|
RU2620857C1 |
MULTICOMPONENT COMPOSITION WITH ANTI-TUBERCULOSIS EFFECT | 2008 |
|
RU2384334C2 |
ANTI-TUBERCULOSIS PREPARATION | 2002 |
|
RU2211035C1 |
Authors
Dates
2015-04-10—Published
2013-10-29—Filed